Tacita Capital’s Boston Scientific BSX Stock Holding History

Tacita Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.2K	Hold	1,200	–	–	0.03%	139
2026 Q1	$75.3K	Hold	1,200	–	–	0.04%	117
2025 Q4	$114K	Hold	1,200	–	–	0.07%	100
2025 Q3	$117K	Hold	1,200	–	–	0.07%	94
2025 Q2	$129K	Hold	1,200	–	–	0.08%	96
2025 Q1	$121K	Hold	1,200	–	–	0.09%	94
2024 Q4	$107K	Hold	1,200	–	–	0.08%	97
2024 Q3	$101K	Hold	1,200	–	–	0.07%	102
2024 Q2	$92.4K	Hold	1,200	–	–	0.07%	104
2024 Q1	$82.2K	Hold	1,200	–	–	0.06%	117
2023 Q4	$69.4K	Hold	1,200	–	–	0.05%	119
2023 Q3	$63.4K	Hold	1,200	–	–	0.05%	133
2023 Q2	$65K	Hold	1,200	–	–	0.05%	122
2023 Q1	$60K	Hold	1,200	–	–	0.05%	122
2022 Q4	$56K	Hold	1,200	–	–	0.04%	119
2022 Q3	$46K	Hold	1,200	–	–	0.04%	126
2022 Q2	$45K	Hold	1,200	–	–	0.03%	138
2022 Q1	$53K	Hold	1,200	–	–	0.03%	143
2021 Q4	$51K	Hold	1,200	–	–	0.03%	143
2021 Q3	$52K	Hold	1,200	–	–	0.03%	133
2021 Q2	$51K	Buy	+1,200	New	+$50.5K	0.03%	143

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tacita Capital's BSX Position: Q2 2026 in Review

Tacita Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 1,200 shares worth $51.2K. The position accounts for 0.03% of the portfolio, ranked #139.

Tacita Capital first reported a position in BSX in Q2 2021 and has held it in 21 quarters since. The position peaked at $129K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Tacita Capital held 1,200 shares of Boston Scientific worth $51.2K as of Q2 2026.
Tacita Capital left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.03% of Tacita Capital's portfolio in Q2 2026, its #139 holding.
Tacita Capital first reported a position in Boston Scientific in Q2 2021 and has held it in 21 quarters since.
Tacita Capital's Boston Scientific position peaked at $129K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tacita Capital's 13F filing for Q2 2026, filed 10 Aug 2026.